Sleep drug may increase risk of falls, study finds

11/20/2012 | U.S. News & World Report

Mayo Clinic researchers examined data on more than 16,000 hospitalized patients in the U.S., and found that those who received the sleeping pill Ambien, or zolpidem, fell at a rate four times greater than those who didn't receive the treatment. Due to the research, Mayo is transitioning to other sleep-enhancement treatments, said Dr. Timothy Morgenthaler, Mayo's chief patient safety officer.

View Full Article in:

U.S. News & World Report

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA